Related Experiment Video
Updated: Jan 7, 2026
Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model
Published on: October 20, 2023
MFSD2A: a molecular nexus linking blood-brain barrier, lipid metabolism, and ischemia-reperfusion injury
Chunyan Li1,2, Muhammad Mustapha Ibrahim3,4, Cheng Fang5
1Department of Biomedical Engineering, Southern University of Science and Technology, Shenzhen, Guangdong, People's Republic of China.
Abstract:
Major facilitator superfamily domain-containing protein 2A (MFSD2A) is a central molecular player in maintaining the blood-brain barrier (BBB). It exerts dual protective effects in ischemia-reperfusion injury (IRI): MFSD2A regulates the lipid composition of brain endothelial cell membranes through its sodium-dependent transport of docosahexaenoic acid-conjugated lysophosphatidylcholine (LPC-DHA); this lipid remodeling thereby maintains the characteristic low permeability of the BBB by suppressing caveolae-mediated transcytosis. This review systematically analyzes the tissue distribution patterns of MFSD2A, the protein structural features, and its biological functions both in physiological and pathological conditions. We further reveal its cell type-specific regulatory networks. Notably, acute-phase of IRI induces downregulation of MFSD2A and subsequent BBB leakage. MFSD2A not only serves as a molecular switch to enhance brain-targeted drug delivery (e.g., temporarily inhibiting its activity to improve nanoparticle transport across the BBB) but may also become a therapeutic target for maintaining BBB integrity (e.g., agonist development). This review provides a novel framework for understanding MFSD2A's multidimensional mechanisms in neurological diseases and its potential for clinical translation.
Insights
Major facilitator superfamily domain-containing protein 2A (MFSD2A) maintains blood-brain barrier (BBB) integrity by regulating lipid composition. Downregulation of MFSD2A during injury compromises the BBB, highlighting its therapeutic potential for neurological diseases and drug delivery.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Major facilitator superfamily domain-containing protein 2A (MFSD2A) is crucial for blood-brain barrier (BBB) integrity.
- MFSD2A regulates endothelial cell membrane lipid composition via lysophosphatidylcholine transport.
- This lipid remodeling is essential for suppressing transcytosis and maintaining low BBB permeability.
Purpose of the Study:
- To systematically review MFSD2A's tissue distribution, structural features, and functions in physiological and pathological states.
- To elucidate MFSD2A's cell type-specific regulatory networks.
- To explore MFSD2A's dual role in BBB integrity and its potential for therapeutic applications and drug delivery.
Main Methods:
- Systematic literature review and analysis.
- Analysis of protein structure and function.
- Examination of regulatory networks and disease models.
Main Results:
- MFSD2A regulates BBB permeability by controlling lysophosphatidylcholine-docosahexaenoic acid (LPC-DHA) transport.
- Ischemia-reperfusion injury (IRI) downregulates MFSD2A, leading to BBB leakage.
- MFSD2A's activity can be modulated to enhance drug delivery or maintain BBB integrity.
Conclusions:
- MFSD2A is a key regulator of BBB function and integrity, particularly during neurological injury.
- MFSD2A presents a promising therapeutic target for neurological diseases and a modulator for brain-targeted drug delivery.
- Understanding MFSD2A's mechanisms offers a novel framework for clinical translation in neurology.
